SIH Partners’s CureVac CVAC Stock Holding History

SIH Partners’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,507	Closed	-$40.2K	–	206
2025 Q1	$40.2K	Buy	+14,507	New	+$50.5K	﹤0.01%	256

Other funds holding CVAC

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

SIH Partners's CVAC Position: Q2 2025 in Review

SIH Partners sold out of CureVac (CVAC) in Q2 2025, closing a stake of 14,507 shares — an estimated $40.2K sold.

SIH Partners first reported a position in CVAC in Q1 2025 and held it in 1 quarter. The position peaked at $40.2K in Q1 2025. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

SIH Partners reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 14,507 CureVac shares in Q2 2025, an estimated $40.2K.
SIH Partners first reported a position in CureVac in Q1 2025 and held it in 1 quarter.
SIH Partners's CureVac position peaked at $40.2K in Q1 2025.
91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.